Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'GLYCOPROTEIN IIB/IIIA ANTAGONIST' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 23 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Abulencia, JP; Tien, N; McCarty, OJT; Plymire, D; Mousa, SA; Konstantopoulos, K
      Comparative antiplatelet efficacy of a novel, nonpeptide GPIIb/IIIa antagonist (XV454) and abciximab (c7E3) in flow models of thrombosis

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    2. Easton, JD
      Future perspectives for optimizing oral antiplatelet therapy

      CEREBROVASCULAR DISEASES
    3. Klinkhardt, U; Graff, J; Westrup, D; Kirchmaier, CM; Esslinger, HU; Breddin, HK; Harder, S
      Pharmacodynamic characterization of the interaction between abciximab or tirofiban with unfractionated or a low molecular weight heparin in healthy subjects

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    4. Mousa, SA; Forsythe, MS
      Comparison of the effect of different platelet GPIIb/IIa antagonists on the dynamics of platelet/fibrin-mediated clot strength induced using thromboelastography

      THROMBOSIS RESEARCH
    5. Yang, Y; Li, Q; Nakada, MT; Yang, T; Shuaib, A
      Angiographic evaluation of middle cerebral artery reperfusion caused by platelet glycoprotein IIb/IIIa receptor complex antagonist murine 7E3 F(ab ')(2) in a model of focal cerebral ischemia in rats

      JOURNAL OF NEUROSURGERY
    6. Patrono, C; Coller, B; Dalen, JE; FitzGerald, GA; Fuster, V; Gent, M; Hirsh, J; Roth, G
      Platelet-active drugs - The relationships among dose, effectiveness, and side effects

      CHEST
    7. Mousa, SA; Bozarth, JM; Naik, UP; Slee, A
      Platelet GPIIb/IIIa binding characteristics of small molecule RGD mimetic:distinct binding profile for Roxifiban

      BRITISH JOURNAL OF PHARMACOLOGY
    8. Koestenberger, M; Gallistl, S; Cvirn, G; Roschitz, B; Muntean, W
      Effects of the glycoprotein IIb/IIIa receptor antagonist c7E3 Fab and anticoagulants on platelet aggregation and thrombin potential under high coagulant challenge in vitro

      BLOOD COAGULATION & FIBRINOLYSIS
    9. Mousa, SA; Forsythe, M; Bozarth, J; Jin, FQ; Confalone, PN
      Human platelet alpha IIb beta 3 integrin binding affinity end specificity of SJ874: antiplatelet efficacy versus aspirin

      CORONARY ARTERY DISEASE
    10. Wittke, B; Ensor, H; Chung, J; Birnbock, H; Lausecker, B; Ertel, SI; Mackie, IJ; Machin, SJ
      Pharmacokinetics and pharmacodynamics of sibrafiban alone or in combination with ticlopidine and aspirin

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    11. Ono, S; Inoue, Y; Yoshida, T; Kosaka, K; Maeda, K; Imada, T; Fukaya, C; Nakamura, N
      Molecular modelling and conformational analysis of novel glycoprotein (Gp)IIb/IIIa antagonists. Molecular orbital calculation and the condensed heterocyclic derivatives

      EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
    12. Wang, W; Camenisch, G; Sane, DC; Zhang, HJ; Hugger, E; Wheeler, GL; Borchardt, RT; Wang, BH
      A coumarin-based prodrug strategy to improve the oral absorption of RGD peptidomimetics

      JOURNAL OF CONTROLLED RELEASE
    13. Mousa, SA; Bozarth, JM; Forsythe, MS; Slee, A
      Differential antiplatelet efficacy for various GPIIb/IIIa antagonists: Role of plasma calcium levels

      CARDIOVASCULAR RESEARCH
    14. Braunwald, E; Califf, RM; Cannon, CP; Fox, KAA; Fuster, V; Gibler, WB; Harrington, RA; King, SB; Kleiman, NS; Theroux, P; Topol, EJ; Van de Werf, F; White, HD; Willerson, JT
      Redefining medical treatment in the management of unstable angina

      AMERICAN JOURNAL OF MEDICINE
    15. Mousa, SA
      Antiplatelet therapies: from aspirin to GPIIb/IIIa-receptor antagonists and beyond

      DRUG DISCOVERY TODAY
    16. Geiger, J
      Anti-aggregatory drugs: I. Platelet receptor antagonists

      EXPERT OPINION ON THERAPEUTIC PATENTS
    17. Amidon, TM; Amidon, JB; Benson, JM; Coffler, D
      Tirofiban and intracoronary stenting: Evaluation of a new pharmacologic regimen

      JOURNAL OF INVASIVE CARDIOLOGY
    18. Becker, RC
      New thrombolytic, anticoagulants, and platelet antagonists: The future of clinical practice

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    19. Modi, NB; Novotny, M; Reimann, JD; Cannon, CP; Braunwauld, E
      Pharmacokinetics and pharmacodynamics of sibrafiban, an orally administered IIb IIIa antagonist, in patients with acute coronary syndrome

      JOURNAL OF CLINICAL PHARMACOLOGY
    20. Banno, H; Kawazura, H; Yutaka, T; Sakuma, N; Kitamori, T; Hosoya, J; Kibayashi, K; Yamashita, H; Umemura, K; Nakashima, M
      Antiaggregatory, antithrombotic effects of MS-180, a novel platelet glycoprotein IIb/IIIa receptor antagonist

      EUROPEAN JOURNAL OF PHARMACOLOGY
    21. Goa, KL; Noble, S
      Eptifibatide - A review of its use in patients with acute coronary syndromes and/or undergoing percutaneous coronary intervention

      DRUGS
    22. MEYER BJ
      ANTITHROMBOTIC DRUGS - INSIGHTS FROM CARDIOLOGY

      Cerebrovascular diseases
    23. DOMANOVITS H; NIKFARDJAM M; JANATA K; HORNYKEWYCZ S; MAURER G; LAGGNER AN; HUBER K
      RESTORATION OF CORONARY BLOOD-FLOW BY SINGLE BOLUS INJECTION OF THE GPIIB IIIA RECEPTOR ANTAGONIST C7E3 FAB IN A PATIENT WITH ACUTE MYOCARDIAL-INFARCTION OF RECENT-ONSET/

      Clinical cardiology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/01/21 alle ore 23:43:24